Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years

Recruiting N/A Interventional Study
Infertility
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 41
Sex
Female
Study type
Interventional
Purpose
Diagnostic
Participants needed
590 (estimated)
Sponsor
Rigshospitalet, Denmark · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

A multinational multi-centre, randomized, controlled non-blinded trial with participation of three fertility clinics in Denmark and one in Spain to assess the efficacy and safety of preimplantation genetic testing for aneuploidy (PGT-A) in 37-41-year-old women.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women aged 37-41 years with a male partner, a female partner og undergoing fertility with no partner. * Anti Müllerian Hormone (AMH) ≥6.28 pmol/L (AMH should be measured no more than one year prior to study inclusion). The optimal is to use the Elecsys® Assay. If other assays …
Contacts

Anja Bisgaard Pinborg, MD

+4535454071

anja.bisgaard.pinborg@regionh.dk

CONTACT